The Medical Mind

In this episode of Psychiatric News Special Report, Dr. Sulman Aziz Mirza speaks with Dr. Sarah El Halabi and Dr. Stephen J. Ferrando about why lithium remains underused despite its established role in treating bipolar disorder. They explore how specialized lithium clinics and standardized monitoring can support safer prescribing for pregnant and postpartum patients, older adults, and people with renal disease. The conversation also addresses misconceptions about lithium toxicity, the challenges of managing complex medications, and the importance of coordinated, team-based care.

PsychNews Special Report is a production of Psychiatric News, a media platform dedicated to serving as the primary and most trusted source of information for APA members, other psychiatrists and physicians, health professionals, and the public about developments in the field of psychiatry and mental health that impact clinical care and professional practice. Learn more at psychiatryonline.org/journal/pn

In this episode Dr. Gupta is joined  by Theresa Miskimen Rivera, MD, DLFAPA.  Dr. Miskimen Rivera is the former President of the American Psychiatric Association; a Distinguished Life Fellow of the American Psychiatric Association (APA); a member of the American College of Psychiatrists, and Clinical Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. She most recently served as the Medical Quality and Clinical Effectiveness Officer for Behavioral Health in the Department of Psychiatry at Hunterdon Medical Center in Flemington, New Jersey. Dr. Miskimen centered her public-sector clinical practice on improving access to and delivery of psychiatric care for bilingual and bicultural communities, developing and implementing intercultural clinical programs, and serving as a consulting psychiatrist for a collaborative care practice in New Jersey. Her clinical work has informed research endeavors, resulting in numerous articles and lectures on diagnostic challenges and symptom phenomenology in treating racially and ethnically diverse populations, as well as on ethical issues affecting psychopharmacological research among ethnic populations and the cultural aspects of patient symptomatology. For over 30 years, Dr. Miskimen has applied her passion and expertise to critical roles, including psychiatric clinical care, patient advocacy, community outreach, academic endeavors, and organizational leadership. Dr. Miskimen has served in numerous community-facing initiatives and appointed positions under three past Governors of the State of New Jersey, addressing mental health issues spanning the intersection of technology and the delivery of psychiatric care, mental health in university settings, and youth suicide prevention. She has served as an APA Delegate to the American Medical Association Section Council on Psychiatry. She is also a member of the Steering Committee for the American Academy of Pediatrics Wellness through Equity and Leadership (WEL) program, which is tasked with developing a training curriculum and leadership experience for women physicians, mentoring participants, and establishing principles on equitable work environments.

In this episode of Mental Health Pathfinders, Dr. John Torous, chair of the American Psychiatric Association's Council on Digital Health, Innovation, and Technology, explores the rapidly evolving role of artificial intelligence in mental health care. He discusses the opportunities and limitations of AI-supported care, the risks of long-term chatbot use, privacy concerns, and the importance of maintaining human connection. The conversation also highlights the council's work to educate clinicians, shape responsible policy, and develop practical frameworks for evaluating new technologies.

In this June episode of Psychiatric News Special Report, host Dr. Sulman Aziz Mirza speaks with Dr. Heather Murray of the University of Colorado about clinical considerations for cannabis use in inpatient medical settings. The conversation examines how high-potency cannabis and concentrates have changed the clinical picture, including intoxication, withdrawal, hyperemesis, psychosis risk, delirium, catatonia, medication interactions, and self-directed discharge. Dr. Murray also emphasizes balanced, stigma-free assessment and the importance of asking about formulation, potency, route, frequency, and last use when caring for patients across medical and psychiatric settings.

In this episode of Mental Health Pathfinders, host Erin Connors speaks with APA President Mark H. Rapaport, M.D., about his vision for the year ahead and the role members can play in advancing psychiatry. Dr. Rapaport discusses APA's strategic priorities, the future of the DSM, and the importance of medical leadership, member engagement, and stronger communication throughout the organization. The conversation also examines urgent challenges facing psychiatrists and their patients, including scope creep, ghost panels, mental health parity, stigma, misinformation, and the effects of social media. Drawing on examples from crisis care and health economics, Dr. Rapaport explains how psychiatrists can demonstrate the value of their work and turn their experiences into effective advocacy for patients, communities, and the profession.